Abbott's troubled baby formula Michigan plant to reopen In 1-2 weeks
Abbott's troubled baby formula Michigan plant to reopen In 1-2 weeks
$Abbott Laboratories(ABT.US)$ and the FDA are reportedly on track to reopen the company's Sturgis, Michigan, baby formula manufacturing plant within one or two weeks, FDA Commissioner Robert Califf said.
Abbott, the biggest U.S. supplier of powder infant formula, including Similac, agreed with the FDA on the steps needed to resume production at the manufacturing plant.
"I think we are on track to get it open within the next week to two weeks, most likely at the outer bound two weeks," Califf told lawmakers at a U.S. House of Representatives Appropriations Subcommittee hearing.
The company initiated a recall of its infant formula products. In February, it closed the plant after reports of serious bacterial infections in four infants, which worsened due to the pandemic supply chain issues.
Price Action: ABT shares were up 1.17% at $113.75 during the premarket session on the last check Friday.
$雅培(ABT.US)$FDA专员罗伯特·卡里夫表示，据报道，FDA将在一到两周内重新开放该公司位于密歇根州斯特吉斯的婴儿配方奶粉制造厂。
雅培是包括Similac在内的美国最大的婴儿配方奶粉供应商，该公司与FDA就恢复制造厂生产所需的步骤达成了一致。
卡里夫在美国众议院拨款委员会的听证会上对议员们说：“我认为我们有望在未来一到两周内将其投入使用，最有可能的是在外围两周内开放。”
该公司启动了对其婴儿配方奶粉产品的召回。今年2月，在有报道称四名婴儿受到严重细菌感染后，该公司关闭了这家工厂，由于大流行的供应链问题，情况恶化。
价格行动：上周五最后一次开盘前交易时段，ABT股价上涨1.17%，至113.75美元。